Duplicate genes in plant genomes, an eye-opener for crop development plans

When plant geneticists discover a gene that boosts crop yields, they want to see if they can replicate the effect in other crops. However, Zachary Lippman, a professor at Cold Spring Harbor Laboratory and an HHMI investigator, warns that understanding what a single gene accomplishes will not be enough. He discovered that knowing what other strongly linked genes might be hiding in the genome to prevent the desired change is beneficial.

Duplicate genes in plant genomes, an eye-opener for crop development plans
Tweaking one plant gene can increase desirable traits, but changing the same gene in another type of plant may not yield the same result. A tobacco plant with a mutation engineered in the clv3 gene makes larger and more numerous stems, branches, and flower tissues. CSHL researchers discovered the same mutation in evolutionarily-related plants produces different effects. Image Credit: Choon-Tak Kwon/Lippman lab

Lippman, former postdoc Cao Xu (currently at the Chinese Academy of Sciences in Beijing), and colleagues show how duplicated genes in plant genomes hamper crop development plans. Plants have a lot of gene duplications. Many of these actions serve as “backup copies” of the original gene. The study was published in Nature Plants.

However, Lippman claims that having a good candidate for gene editing would not be enough to determine the outcome of planned modifications, based on his team’s astounding discoveries.

The lack of predictability in the context of a duplicate gene really needs to be an eye-opener for designing crop improvements.”

Zachary Lippman, Professor and HHMI Investigator, Cold Spring Harbor Laboratory

The researchers looked at the clv3 gene. This gene creates a protein that prevents developing plant tissues from growing too large. Many domestic plants have increased yields as a result of clv3 mutations. Mutations in the clv3 gene, for example, are linked to larger fruits with more seed sections in tomatoes.

In tomato, tobacco, ground cherry, and petunia plants, Lippman’s team inserted identical mutations into the clv3 gene. The Solanaceae family, usually known as nightshades, includes all four plants. Lippman and his colleagues were expecting similar results, but what he discovered was surprising.

The impacts were striking in tobacco, with certain growth zones doubling in size. The plant’s loss of the clv3 backup gene caused this alteration. Since the duplicated gene partially cushions clv3 mutations in tomatoes, the impacts were milder. Mutating clv3 in in-ground cherry and petunia showed no effect. Both plants possessed clv3-like genes, which compensated for the clv3 gene modifications introduced by the researchers.

The lesson, according to Lippman, is that improving crops by genome editing may necessitate a list of duplicated genes. Crop developers must know how essential genes have been replicated, eliminated, and modified throughout time. Scientists will be able to design more predictable agricultural advances as a result of this.

Source:
Journal reference:

Kwon, C-T., et al. (2022) Dynamic evolution of small signaling peptide compensation in plant stem cell control. Nature Plants. doi.org/10.1038/s41477-022-01118-w.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Integrative genomic study identifies two new potential drug targets in Mycobacterium tuberculosis